Literature DB >> 30551844

Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients.

Berna Akkus Yildirim1, Yemliha Dolek1, Ozan Cem Guler1, Gungor Arslan1, Cem Onal2.   

Abstract

We performed this dosimetric study to compare a nonstandard volumetric modulated arc therapy (VMAT) and helical tomotherapy (HT) techniques with high-dose rate (HDR) brachytherapy (BRT) plan of vaginal vault in patients with postoperative endometrial cancer (EC). Twelve postoperative patients with early stage EC were included in this study. Three plans were performed for each patient; dosimetric and radiobiological comparisons were made using dose-volume histograms and equivalent dose for determining the planning target volume (PTV) coverages in brachytherapy and external beam radiotherapy, and organs-at-risk (OARs) doses between three different delivery techniques. All the plans achieved adequate dose coverage for PTV; however, the VMAT plan yielded better dose conformity, and the HT plan showed better homogeneity for target volume. With respect to the OARs, the bladder D2cc was significantly lower in the BRT plan than in the VMAT and HT plans, with the highest bladder D2cc value being observed in the HT plan. However, no difference was observed in the rectum D2cc of the three plans. Other major advantages of the BRT plan over the VMAT and HT plans were the relatively lower body integral doses and femoral head doses as well as the fact that the integral doses were significantly lower in the BRT plan than in the VMAT and HT plans. This is the first dosimetric comparison of vaginal vault treatment for EC with BRT, VMAT, and HT plans. Our analyses showed the feasibility of stereotactic body radiotherapy technique as an alternative to HDR-BRT for postoperative management of EC patients.
Copyright © 2018 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brachytherapy; Endometrium cancer; Helical tomotherapy; Sterotactic radiotherapy; Volumetric arc therapy

Mesh:

Year:  2018        PMID: 30551844     DOI: 10.1016/j.meddos.2018.11.005

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  Proton Arc Therapy vs Interstitial HDR Brachytherapy in Gynecologic Cancer with Parametrial/pelvic Side Wall Extension.

Authors:  ByongYong Yi; Sina Mossahebi; Arezoo Modiri; Elizabeth M Nichols; Mariana Guerrero; Narottam Lamichhane; Pranshu Mohindra
Journal:  Int J Part Ther       Date:  2022-06-28

Review 2.  The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry.

Authors:  Tibor Major; Georgina Fröhlich; Péter Ágoston; Csaba Polgár; Zoltán Takácsi-Nagy
Journal:  Strahlenther Onkol       Date:  2021-11-01       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.